…antioxidant benefits and taking them to the next level into the pharma space,” added James Berger, CCO at HBC.” Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
…The researchers will next study thymic stem cell properties throughout life and how to manipulate them for potential therapies. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
…patients face.” EMMs are a broad family of molecules, including amino acids, which fundamentally impact and regulate human metabolism. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
…designed to evaluate the safety, tolerability, immunogenicity and preliminary efficacy of 8mg of ITI-1001 in newly diagnosed GBM patients. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
Join DDW for this exclusive free event, Are in vitro metabolism and drug-drug interaction studies critical for an investigational new drug application? which is supported by BioIVT. Expert Dr Andrew…
…this in mind, there is much optimism – and great expectations – about pharma’s ability to tackle future crises.” Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
…on the latest industry updates. The headline news this week reflects the high level of interest and investment in neuroscience drug discovery, particularly neurodegenerative diseases like Alzheimer’s; including positive clinical…
…is underway for a Phase II study that is expected to begin enrolling patients in H1 (first half) 2024. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
…of drug and gene therapies’ will take place on 28 September 4PM BST, 5PM CEST, EDT 11AM, PDT 8AM. Register now. Speakers: Chris Kirton, Chief Executive Officer, DefiniGEN Prof Ludovic…
A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may…
…frustrated scientists and damaged the UK’s reputation as a science leader and an investment location. Time is of the essence.” By Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
News round-up for 21-25 August by DDW Digital Content Editor Diana Spencer. The headline news this week reflects the high level of interest and investment in neuroscience drug discovery, particularly…
…groups can join Clinical Trials For All as a partner, joining current Platinum Partners include Virtue Research and MedVector. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
…prevention research and for public health in general, as this is one more study demonstrating the value of vaccination.” Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
…in scaling their operations and emphasising health equity, CancerX aims to announce their first demonstration project in April 2024. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
